These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6319882)

  • 1. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3.
    Ward SJ; Pierson AK; Michne WF
    Life Sci; 1983; 33 Suppl 1():303-6. PubMed ID: 6319882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profiles of tonazocine (Win 42156) and zenazocine (Win 42964).
    Ward SJ; Pierson AK; Michne WF
    Neuropeptides; 1985 Feb; 5(4-6):375-8. PubMed ID: 2860595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.
    Koman A; Kolb VM; Terenius L
    Pharm Res; 1987 Apr; 4(2):147-9. PubMed ID: 2855368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa.
    Yamamoto LT; Horie S; Takayama H; Aimi N; Sakai S; Yano S; Shan J; Pang PK; Ponglux D; Watanabe K
    Gen Pharmacol; 1999 Jul; 33(1):73-81. PubMed ID: 10428019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies.
    Kaneto H; Takahashi M; Watanabe J
    J Pharmacobiodyn; 1990 Jul; 13(7):448-53. PubMed ID: 1963196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid activity and receptor selectivity of fluorinated Leu5 enkephalin analogues in vitro and in vivo.
    Watanabe J; Tokuyama S; Takahashi M; Kaneto H; Maeda M; Kawasaki K; Taguchi T; Kobayashi Y; Yamamoto Y; Shimokawa K
    J Pharmacobiodyn; 1991 Feb; 14(2):101-5. PubMed ID: 1651391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YFa and analogs: investigation of opioid receptors in smooth muscle contraction.
    Kumar K; Goyal R; Mudgal A; Mohan A; Pasha S
    World J Gastroenterol; 2011 Oct; 17(40):4523-31. PubMed ID: 22110284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.